Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

ClinicalTrials.gov ID: NCT03834753

Public ClinicalTrials.gov record NCT03834753. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 7:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Clinical Effectiveness, Multicenter, Randomized, Double-masked, Controlled Study of the Efficacy and Safety of ONS-5010 in Subjects With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration

Study identification

NCT ID
NCT03834753
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Outlook Therapeutics, Inc.
Industry
Enrollment
228 participants

Conditions and interventions

Interventions

  • bevacizumab Biological
  • ranibizumab Biological

Biological

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 24, 2019
Primary completion
Jun 6, 2021
Completion
Jul 7, 2021
Last update posted
Mar 18, 2025

2019 – 2021

United States locations

U.S. sites
50
U.S. states
21
U.S. cities
49
Facility City State ZIP Site status
Clinical Site Tucson Arizona 85710
Clinical Site Arcadia California 91007
Clinical Site Beverly Hills California 90211
Clinical Site Campbell California 95008
Clinical Site Glendale California 91203
Clinical Site Laguna Hills California 92653
Clinical Site Long Beach California 90807
Clinical Site Mountain View California 94040
Clinical Site Oxnard California 93036
Clinical Site Palm Desert California 92260
Clinical Site Poway California 92064
Clinical Site Sacramento California 95841
Clinical Site Santa Maria California 93454
Clinical Site Tustin California 92780
Clinical Site Golden Colorado 80401
Clinical Site Hamden Connecticut 06518
Clinical Site Clearwater Florida 33761
Clinical Site Pinellas Park Florida 33782
Clinical Site Sarasota Florida 24233
Clinical Site Winter Haven Florida 33880
Clinical Site Augusta Georgia 30909
Clinical Site Marietta Georgia 30060
Clinical Site Downers Grove Illinois 60615
Clinical Site Lemont Illinois 60439
Clinical Site Springfield Illinois 62704
Clinical Site Indianapolis Indiana 46290
Clinical Site Hagerstown Maryland 21740
Clinical Site Edina Minnesota 55435
Clinical Site St Louis Missouri 63144
Clinical Site Bloomfield New Jersey 07003
Clinical Site Albuquerque New Mexico 87109
Clinical Site New York New York 10021
Clinical Site Chambersburg Pennsylvania 17201
Clinical Site Monroeville Pennsylvania 15146
Clinical Site Rapid City South Dakota 57701
Clinical Site Germantown Tennessee 38138
Clinical Site Abilene Texas 79606
Clinical Site Amarillo Texas 79106
Clinical Site Arlington Texas 76012
Clinical Site Dallas Texas 75231
Clinical Site Grapevine Texas 76051
Clinical Site Houston Texas 77030
Clinical Site McAllen Texas 78503
Clinical Site San Antonio Texas 78240
Clinical Site San Antonio Texas 78251
Clinical Site The Woodlands Texas 77384
Clinical Site Willow Park Texas 76807
Clinical Site Salt Lake City Utah 84107
Clinical Site Norfolk Virginia 23502
Clinical Site Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03834753, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 18, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03834753 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →